Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114634481B reveals copper-mediated method improving substrate scope. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105085419A details novel catalytic method ensuring high purity and scalable production for reliable pharmaceutical intermediate supply chains globally.
Patent CN115850240B reveals a two-step route for Olutasidenib. This method ensures high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN108752290B details a high-yield TTP/HFIP catalytic route for benproperine phosphate, offering significant cost reduction and purity improvements for API manufacturers.
Patent CN103214407B details silver-catalyzed sp3 C-H amination for tetrahydropyrrole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN104797563B reveals improved in-situ synthesis of activated fumarate intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical excipient manufacturing.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.
Patent CN110627693A reveals efficient allyl sulfone synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN114369053B reveals a metal-free route for high-purity sulfonylated pyrrolidone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105153020A details a novel four-step synthesis route for aromatic azides offering significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthetic route for 7-chloro-2,2-dimethylheptanoate using 1-bromo-5-chloropentane. Achieves high purity, minimizes byproducts, and enables scalable manufacturing for lipid-lowering APIs.
Patent CN110284149A details a green electrochemical route for mesocyclic lactams, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104892472A details a novel bis-chiral sulfoxide-alkene ligand synthesis enabling high-efficiency rhodium-catalyzed asymmetric allylation for pharmaceutical intermediate manufacturing.
Novel synthetic route for veranamine offers cost reduction in pharma intermediate manufacturing with scalable catalytic steps and high purity specifications for global supply chains.
Novel thiophosgene-free route for enzalutamide intermediates. Enhances supply chain safety and reduces genotoxic risks for pharmaceutical manufacturing partners globally.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN115010716B reveals mild cyclization for polysubstituted pyridines. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.